Ginkgo Bioworks Holdings (DNA) Other Non-Current Assets (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) posted Other Non-Current Assets of $39.5 million for Q1 2026, down 16.21% on a QoQ basis from $47.2 million in Q4 2025, and down 15.51% year-over-year from $46.8 million in Q1 2025.

Ginkgo Bioworks Holdings (DNA) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Ginkgo Bioworks Holdings' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $39.5 million for Q1 2026.

  • Quarterly Other Non-Current Assets fell 15.51% year-over-year to $39.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.5 million (down 15.51% YoY) and the FY2025 annual result came in at $47.2 million, down 14.76% from the prior year.
  • Other Non-Current Assets was $39.5 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $47.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $97.9 million in Q2 2023 and bottomed at $39.5 million in Q1 2026.
  • A 5-year average of $61.7 million and a median of $55.3 million in 2024 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 8223.17% — and 2024, when it sank 38.53%.
  • Ginkgo Bioworks Holdings' Other Non-Current Assets stood at $88.7 million in 2022, then tumbled by 34.57% to $58.1 million in 2023, then slipped by 4.68% to $55.3 million in 2024, then dropped by 14.76% to $47.2 million in 2025, then retreated by 16.21% to $39.5 million in 2026.
  • Business Quant data shows DNA's Other Non-Current Assets at $39.5 million in Q1 2026, $47.2 million in Q4 2025, and $46.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Ginkgo Bioworks Holdings 517.16 Mn 373.30 Mn 16.38 Mn 39.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 39.52 Mn
Dec 31, 2025 47.17 Mn
Sep 30, 2025 46.59 Mn
Jun 30, 2025 47.02 Mn
Mar 31, 2025 46.78 Mn
Dec 31, 2024 55.34 Mn
Sep 30, 2024 59.79 Mn
Jun 30, 2024 60.21 Mn
Mar 31, 2024 60.63 Mn
Dec 31, 2023 58.06 Mn
Sep 30, 2023 97.02 Mn
Jun 30, 2023 97.95 Mn
Mar 31, 2023 97.26 Mn
Dec 31, 2022 88.73 Mn
Sep 30, 2022 43.93 Mn
Jun 30, 2022 53.02 Mn
Mar 31, 2022 49.62 Mn
Dec 31, 2021 1.07 Mn
Sep 30, 2021 26.80 Mn
Dec 31, 2020 5.60 Mn